![]() |
市場調查報告書
商品編碼
2083430
蚊蟲驅避劑市場:2026-2032年全球市場預測(依劑型、原料、應用方法、使用環境及通路分類)Mosquito Repellent Market by Form, Raw Material, Application Method, Usage Environment, Distribution Channel - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,蚊蟲驅避劑市場規模將達到 125 億美元,年複合成長率為 6.16%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 82.2億美元 |
| 預計年份:2026年 | 87.1億美元 |
| 預測年份 2032 | 125億美元 |
| 複合年成長率 (%) | 6.16% |
蚊蟲驅避劑市場涵蓋消費者健康、戶外休閒、旅遊以及蚊媒疾病預防等多個面向。市場需求主要受美國疾病管制與預防中心 (CDC) 和美國環保署 (EPA) 發布的公共衛生指南驅動。這些指南建議使用經 EPA 註冊的活性成分,例如避蚊胺 (DEET)、派卡瑞丁、IR3535、檸檬桉油/PMD 和 2-十一烷酮,並嚴格按照標籤說明使用。
氣候變遷、都市化、國際旅行以及消費者對蟲媒疾病日益增強的認知正在重塑市場格局。公共衛生部門越來越認可驅蚊劑作為一種實用的個人防護措施,並將其與經殺蟲劑處理的蚊帳、紗窗、衛生設施和社區蚊蟲控制措施並列使用。
人工智慧 (AI) 正透過媒介監測、預測分析、配方篩檢和需求預測等方式,開始影響蚊蟲驅避劑的價值鏈。人工智慧模型整合了天氣數據、衛星數據、誘蚊器數據和疾病報告數據,以識別蚊蟲滋生壓力,並幫助製造商調整庫存,以滿足季節性和感染疾病爆發相關的需求模式。
由於人口密度高、氣候屬熱帶和亞熱帶地區,以及登革熱和瘧疾在南亞和東南亞地區反覆出現,亞太地區仍然是重要的需求中心。世界衛生組織已將西太平洋和東南亞地區列為登革熱流行重點地區,印度、印尼、泰國和菲律賓等國的公共衛生機構持續強調在流行季節採取預防措施避免蚊蟲叮咬的重要性。
東協市場受多種因素影響,例如登革熱的流行風險、熱帶氣候、人口稠密的都市區,以及蚊香、蚊香噴霧、蚊香液、蚊香噴霧、蚊香液、蚊香液、蚊香貼和蚊香外用產品的廣泛使用。東南亞各地的公共衛生宣傳活動始終強調減少蚊蟲滋生地和預防叮咬,家用害蟲防治產品和個人蚊香在都市區和郊區發揮著至關重要的作用。
在美國,由美國環保署(EPA)註冊的驅蚊產品、戶外休閒、西尼羅河病毒預防指南以及美國疾病管制與預防中心(CDC)支持的活性成分建議發揮主導作用。而在加拿大,人們則更重視季節性使用、標籤檢視符合規定的功效聲明以及在溫暖季節的防護。在墨西哥和巴西,人們對登革熱、茲卡病毒病和屈公病的認知度更高,對家用和個人蚊蟲控制產品的需求日益成長,尤其是在埃及伊蚊反覆引發公共衛生問題的都市區和熱帶地區。
行業領導者應優先考慮產品功效的透明度、清晰的活性成分說明以及符合監管標準的功效聲明。品牌若能解釋防護持續時間、針對不同年齡層的使用指南、使用頻率、補塗需求以及與防曬油搭配使用的方法,將有助於增強消費者信心並減少誤用。
本執行摘要基於二手研究,參考了公共衛生機構、監管機構、科學文獻、產品標籤、零售現場觀察和行業資訊來源。主要參考資料包括世界衛生組織疾病監測數據、美國疾病管制與預防中心預防指南、美國環保署殺蟲劑登記資訊、地方除生物劑框架以及國家和地方衛生部門的公共建議。
蚊蟲驅避劑市場正從一個季節性、以便利性為導向的品類,轉變為預防保健和居家安全的核心要素。疾病負擔日益加重、蚊蟲活動受氣候影響、外來物種入侵蔓延,以及消費者對安全有效成分日益成長的需求,都持續支撐著這一品類的蓬勃發展。
The Mosquito Repellent Market is projected to grow by USD 12.50 billion at a CAGR of 6.16% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 8.22 billion |
| Estimated Year [2026] | USD 8.71 billion |
| Forecast Year [2032] | USD 12.50 billion |
| CAGR (%) | 6.16% |
The mosquito repellent market sits at the intersection of consumer health, outdoor recreation, travel, and vector-borne disease prevention. Demand is reinforced by public health guidance from the CDC and U.S. EPA, which recommend EPA-registered active ingredients such as DEET, picaridin, IR3535, oil of lemon eucalyptus/PMD, and 2-undecanone when used according to label directions.
Market relevance is also supported by the persistent global burden of mosquito-borne disease. The WHO reported an estimated 249 million malaria cases and 608,000 malaria deaths in 2022, while dengue transmission has expanded across tropical and subtropical regions, increasing the relevance of topical repellents, spatial repellents, treated textiles, coils, vaporizers, and household insect control products.
The landscape is being reshaped by climate variability, urbanization, international travel, and growing consumer awareness of vector-borne diseases. Public health authorities increasingly position mosquito repellents as a practical layer of personal protection alongside insecticide-treated nets, screens, sanitation, and community mosquito control.
Product strategy is shifting from basic insect avoidance to evidence-based protection, better skin feel, longer duration, family-friendly labeling, and reduced odor. At the same time, retail is moving toward omnichannel buying, with consumers comparing efficacy claims, active ingredients, dermatology positioning, sustainability credentials, and regulatory approvals before purchase.
Artificial intelligence is beginning to influence the mosquito repellent value chain through vector surveillance, predictive analytics, formulation screening, and demand planning. AI-supported models can combine weather, satellite, trap, and disease-reporting data to identify mosquito pressure and help manufacturers align inventory with seasonal and outbreak-driven demand patterns.
In product development, machine learning can support faster screening of ingredient combinations, controlled-release systems, fragrance masking, and packaging optimization. However, AI does not replace toxicology, field testing, label compliance, or regulatory review; it strengthens decision-making when paired with validated laboratory and real-world performance data.
Asia-Pacific remains a critical demand center because of dense populations, tropical and subtropical climates, and recurring dengue and malaria risk across South and Southeast Asia. WHO has identified the Western Pacific and South-East Asia regions as important dengue-affected areas, while national public health agencies in countries such as India, Indonesia, Thailand, and the Philippines continue to emphasize mosquito-bite prevention during seasonal transmission periods.
North America is shaped by outdoor recreation, West Nile virus awareness, tick-and-mosquito prevention routines, and strong trust in EPA-registered products, particularly in the United States and Canada. Latin America faces sustained dengue pressure, especially in urban areas where Aedes mosquitoes thrive in standing water, and countries across the region have reported recurring dengue, chikungunya, and Zika concerns under Pan American Health Organization surveillance.
Europe is seeing higher attention to invasive mosquito species, including Aedes albopictus, and travel-related disease prevention as warmer seasons and cross-border mobility increase exposure concerns. The Middle East combines expatriate mobility, tourism, irrigation-linked mosquito habitats, and hot-weather outdoor exposure. Africa retains the strongest public health relevance, with WHO data showing the region bears the largest share of malaria cases and deaths, supporting demand for mosquito repellents alongside insecticide-treated nets, indoor residual spraying, environmental management, and broader vector control programs.
ASEAN markets are influenced by endemic dengue risk, tropical climates, dense urban settlements, and high use of coils, vaporizers, sprays, aerosols, lotions, patches, and topical mosquito repellents. Public health messaging across Southeast Asia consistently reinforces source reduction and bite prevention, making household insect control and personal repellent formats important in both urban and peri-urban settings.
The GCC emphasizes premium personal care, travel retail, hospitality, and outdoor evening protection, supported by hot climates, high mobility, and expatriate populations. The European Union prioritizes biocidal product compliance, safety documentation, substantiated efficacy claims, and clear labeling under established regulatory frameworks, making compliance capability a key differentiator for mosquito repellent suppliers.
BRICS countries combine large populations, varied disease exposure, expanding modern retail, and fast-growing e-commerce adoption, creating diverse needs across household, topical, and institutional repellent applications. G7 markets favor clinically credible, regulated, convenient formats, including picaridin, DEET, IR3535, and plant-derived active ingredient options where permitted by regulators. NATO countries show additional demand through military, humanitarian, peacekeeping, and field-deployment use cases where reliable mosquito protection supports operational readiness and personnel health in mosquito-prone environments.
The United States leads with EPA-registered mosquito repellents, outdoor recreation, West Nile virus prevention guidance, and CDC-backed recommendations for active ingredients, while Canada emphasizes seasonal use, label-compliant claims, and protection during warmer months. Mexico and Brazil are more strongly linked to dengue, Zika, and chikungunya awareness, increasing demand for household mosquito control and personal protection, particularly in urban and tropical regions where Aedes aegypti is a recurring public health concern.
In Europe, the United Kingdom, Germany, France, Italy, and Spain balance travel health, summer outdoor use, camping, gardening, and EU biocidal rules, with added attention to invasive mosquito monitoring and prevention advice. Russia faces more seasonal and region-specific demand influenced by climate variation and outdoor activity patterns. China and India represent high-relevance opportunities due to population scale, urbanization, monsoon-linked mosquito activity, and exposure to mosquito-borne diseases in several regions, supporting demand across coils, vaporizers, aerosols, creams, lotions, and plug-in formats.
Japan and South Korea prioritize convenience, quality, low-odor formats, urban household protection, and compact products suited to modern retail and e-commerce channels. Australia combines outdoor lifestyles with mosquito-borne disease prevention in tropical, coastal, and wetland-adjacent areas, where public health authorities routinely advise bite avoidance, protective clothing, screens, and approved repellents during periods of elevated mosquito activity.
Industry leaders should prioritize efficacy transparency, clear active-ingredient education, and claims that align with recognized regulatory standards. Brands that explain duration of protection, age-use guidance, application frequency, reapplication needs, and compatibility with sunscreen can improve consumer trust and reduce misuse.
Manufacturers should diversify across topical, spatial, fabric-treatment, and household formats while investing in long-lasting, low-odor, skin-friendly formulations. Partnerships with retailers, travel health providers, public health campaigns, and e-commerce platforms can strengthen seasonal activation, while AI-enabled demand planning can reduce stockouts during outbreak-driven demand spikes.
Leaders should also localize assortments by climate, disease exposure, consumer format preference, and regulatory status of active ingredients. Evidence-based labeling, post-market safety monitoring, sustainable packaging, and responsible communication around natural or plant-based claims can help improve credibility in both mature and emerging mosquito repellent markets.
This executive summary is grounded in secondary research from public health agencies, regulatory bodies, scientific literature, product labels, retail observations, and trade sources. Key references include WHO disease surveillance, CDC prevention guidance, U.S. EPA repellent registration information, regional biocidal product frameworks, and public advisories from national and regional health authorities.
Insights are synthesized through market segmentation by active ingredient, product format, distribution channel, end user, and geography. Findings are validated through triangulation of disease burden, regulatory acceptance, consumer behavior, vector ecology, climate sensitivity, and commercial availability to ensure practical and data-backed market interpretation without relying on market sizing, share, or forecasting.
The mosquito repellent market is evolving from a seasonal convenience category into a core component of preventive health and household protection. Verified disease burden, climate-sensitive mosquito activity, invasive mosquito expansion, and rising consumer attention to safe, effective ingredients continue to support category resilience.
Future winners will combine regulatory credibility, proven efficacy, convenient formats, and localized go-to-market execution. Organizations that invest in evidence-based innovation, AI-supported planning, responsible claims, and transparent consumer education are best positioned to compete across mature, emerging, and outbreak-sensitive markets.